Quanterix Corporation (QTRX)
| Market Cap | 1.57B |
| Revenue (ttm) | 106.40M |
| Net Income (ttm) | -47.48M |
| Shares Out | 36.65M |
| EPS (ttm) | -0.97 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 348,570 |
| Open | 41.98 |
| Previous Close | 41.88 |
| Day's Range | 40.96 - 43.29 |
| 52-Week Range | 35.02 - 92.57 |
| Beta | 1.45 |
| Analysts | Strong Buy |
| Price Target | 76.00 (+77.7%) |
| Earnings Date | Nov 4, 2021 |
About QTRX
Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also provides SP-X instrument that is based on...
Financial Performance
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for Quanterix stock is "Strong Buy." The 12-month stock price forecast is 76.00, which is an increase of 77.69% from the latest price.
News
Quanterix Recognized as a Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500™
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced it has been r...
Quanterix' Simoa® Technology Powers Advances in Alzheimer's Disease Research Presented at 2021 Clinical Trials on Alz...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix' Simoa® Technology Powers Advances in Alzheimer's Disease Research Presented at 2021 Clinical Trials on Alzheimer's Disease Conference
Quanterix to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
Quanterix Co-Inventor of Simoa® David Walt Receives Kabiller Prize in Nanoscience and Nanomedicine
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, has announced that David Walt...
Quanterix Corporation Releases Operating Results for Third Quarter of 2021
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced financial res...
Analysts Estimate Quanterix Corporation (QTRX) to Report a Decline in Earnings: What to Look Out for
Quanterix Corporation (QTRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quanterix Corporation to Release Third Quarter 2021 Financial Results on Nov. 4, 2021
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation to Release Third Quarter 2021 Financial Results on Nov. 4, 2021
Why Shares of Quanterix Are Climbing This Morning
Regulators are helping accelerate an early test for Alzheimer's disease.
Hot Penny Stocks for Tuesday: Today's 10 Biggest Movers
Penny stocks are on the move Tuesday and we're taking a look at what's hot among traders of the volatile investments today. The post Hot Penny Stocks for Tuesday: Today's 10 Biggest Movers appeared firs...
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based pTau-181 Assay for Alzheimer's Disease
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation granted Breakthrough Device designation from FDA for its blood-based pTau-181 assay for Alzheimer's Disease.
Quanterix Hosts Webinar with Leading Pathologist from Emory Medical Laboratories
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Hosts Webinar with Leading Pathologist from Emory Medical Laboratories
Quanterix Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test
Quanterix to Host Webinar with Leading Pathologist from Emory Medical Laboratories: “COVID-19 Testing in a Residentia...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced a webinar hos...
A Trio of Small Caps for the Growth-Oriented Investor
Investors who are focused on growth could be interested in the following three small-cap stocks, as they represent companies whose trailing 12-month net income per share has improved significantly on a ...
Quanterix Releases Statement
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today released the following statement in res...
Quanterix to Participate in the Canaccord Genuity 41st Annual Growth Conference
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced Chairman and Chief Executive ...
Quanterix Simoa® Technology Powers Breakthrough Alzheimer's Disease Research Presented by Eli Lilly and Company at Al...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that Eli Lill...
Quanterix Corporation (QTRX) Reports Q2 Loss, Tops Revenue Estimates
Quanterix Corporation (QTRX) delivered earnings and revenue surprises of -3.13% and 7.57%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Quanterix Corporation Releases Operating Results for Second Quarter of 2021
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced financial results for the thre...
Quanterix Corporation to Release Second Quarter 2021 Financial Results on Aug. 5, 2021
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it will release its fina...
Will Quanterix Corporation (QTRX) Report Negative Q2 Earnings? What You Should Know
Quanterix Corporation (QTRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quanterix Appoints Michael Doyle as Chief Financial Officer
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it has n...
Quanterix' Simoa Technology Powers Largest and Most Diverse Global Investigation of Plasma Neurofilament Light's Role...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that its Simo...
Quanterix Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference a...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman and Chief Execut...
Quanterix Appoints Masoud Toloue as President of Quanterix and Diagnostics
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company helping to transform healthcare with digital protein biomarker technology enabling precision health, today announced it...